ZimVie (ZIMV) Set to Announce Quarterly Earnings on Wednesday

ZimVie (NASDAQ:ZIMV) is scheduled to be releasing its earnings data after the market closes on Wednesday, May 8th. ZimVie has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Parties that wish to listen to the company’s conference call can do so using this link.

ZimVie (NASDAQ:ZIMV) last issued its quarterly earnings data on Wednesday, February 28th. The company reported $0.10 earnings per share (EPS) for the quarter. The business had revenue of $113.07 million for the quarter. ZimVie had a positive return on equity of 2.44% and a negative net margin of 51.33%.

ZimVie Stock Down 0.2 %

ZIMV opened at $15.80 on Monday. The business’s fifty day simple moving average is $16.64 and its 200 day simple moving average is $14.88. ZimVie has a 52 week low of $6.52 and a 52 week high of $20.91. The firm has a market cap of $430.08 million, a P/E ratio of -1.07 and a beta of 2.17. The company has a quick ratio of 2.32, a current ratio of 2.78 and a debt-to-equity ratio of 1.26.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Needham & Company LLC reiterated a “hold” rating on shares of ZimVie in a report on Thursday, April 11th. Barclays raised their target price on shares of ZimVie from $13.00 to $16.00 and gave the stock an “underweight” rating in a research report on Tuesday, March 5th.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.